Current Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children
| Autor: | Alka Goyal, Melissa Kennedy, Suchitra K. Hourigan, Maire A. Conrad, Stacy A. Kahn, Judith R. Kelsen, Madison Weatherly, Kyle K. Jensen, Maribeth R Nicholson |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Article Food and drug administration 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Pandemic Medicine Humans Practice Patterns Physicians' Child Hepatology business.industry Transmission (medicine) SARS-CoV-2 Gastroenterology COVID-19 Fecal bacteriotherapy Fecal Microbiota Transplantation United States 030220 oncology & carcinogenesis Emergency medicine Clostridium Infections 030211 gastroenterology & hepatology Female business Clostridioides |
| Zdroj: | Am J Gastroenterol |
| Popis: | Introduction The impact of the 2019 US Food and Drug Administration safety alert involving transmission of multidrug resistant organisms through fecal microbiota transplantation (FMT), and the COVID-19 pandemic on the use of FMT in children, is unknown. Methods A survey of pediatric gastroenterologists performing FMT for Clostridioides difficile infection was conducted. Results Of 36 respondents, 17 (47%) and 30 (83%) changed their FMT practices related to the US Food and Drug Administration safety alert and COVID-19 pandemic, respectively, with 22 (61%) of programs halted. Discussion The US Food and Drug Administration safety alert and COVID-19 pandemic have substantially influenced the availability and access of FMT for children. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|